NCT06143644View on ClinicalTrials.gov

Predictive Value of Postoperative Circulating Tumor DNA Monitoring for Colorectal Cancer Recurrence

Active, not recruitingOBSERVATIONAL
Enrollment

220

Participants

Timeline

Start Date

January 15, 2022

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Colorectal Cancer
Interventions
OTHER

Serial ctDNA monitoring

Baseline blood samples, surgical resected tumor tissue, blood samples after surgery (D5-7), blood samples before adjuvant therapy and blood samples after adjuvant therapy (every 3 months for up to 2 years follow-up) will be collected from colorectal patients.

Trial Locations (1)

510060

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors
collaborator

Guangzhou Burning Rock Dx Co., Ltd.

INDUSTRY

lead

Sun Yat-sen University

OTHER